Turtle Cameron Insider Trades

Insider Trading History

Track insider trading activity for Turtle Cameron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $45.7M 622,240 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.07M 15,000 shares
$71.36
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $46.3M 630,196 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$740k 15,000 shares
$49.33
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $47.9M 651,640 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$633k 15,000 shares
$42.19
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $49.4M 671,583 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$492k 15,000 shares
$32.80
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $38.8M 528,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.2M 528,000 shares
$30.61
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $49.6M 674,198 shares
Last Trade
Jan 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$460k 15,000 shares
$30.67
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $50.8M 690,912 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$435k 15,000 shares
$29.02
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $52.8M 718,752 shares
Last Trade
Nov 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.05M 45,000 shares
$23.33
$73.52
Oruka Therapeutics
Oruka Therapeutics ORKA
Director
Holding Value $1M 17,500 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 17,500 shares
$11.77
$57.20
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $27.2M 370,000 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.01M 370,000 shares
$21.66
$73.52
Oruka Therapeutics
Oruka Therapeutics ORKA
Director
Holding Value $0 0 shares
Last Trade
Aug 29, 2024 Sale
No data
No data
$57.20
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $54.9M 746,907 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.02k 400 shares
$22.56
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $20.4M 277,750 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.18M 277,750 shares
$25.86
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $54.9M 746,507 shares
Last Trade
Nov 24, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Executive Officer
Holding Value $8.97M 746,507 shares
Last Trade
Nov 24, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.99M 723,440 shares
$11.04
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$200k 18,086 shares
$11.04
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $27.5M 374,000 shares
Last Trade
Nov 22, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Executive Officer
Holding Value $4.49M 374,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.89M 374,000 shares
$10.39
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Operating Officer
Holding Value $6.93M 576,699 shares
Last Trade
Jun 22, 2023 Sale
$746M 65,383,197 shares
$11.40
$12.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up